Erlotinib Active Not Recruiting Phase 1 Trials for Colon Neoplasms / Lung Cancers / Neoplasms, Breast / Malignant Neoplasm of Colon / Melanoma / Cancer, Breast / Renal Cancers Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00600496A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)